ARCHIVES

Tracor Could Earn $186,000 As Prime Contractor On Carcinogenesis Bioassay

This article is from The Cancer Letter archive.

Vol. 01 No. 12 | April 26, 1974

Download PDF Visit The Full Archive

Related Articles

NCI To File Record No. Of INDS In ’92, Expand Phase 1 Trials

March 6, 1992

Rhoads Presses For Greater Emphasis On Etiology In DNCP; Workshops Develop New Research Leads

July 16, 1976

FDA Hazleton Probe Finds Some Problems; Results Unaffected

April 23, 1976

In Brief: Bioassay Prime Contract Renewed For Four Years, $34.2 Million; Canellos Quits As Clinical Director

June 20, 1975

NIH Plans Meeting On Human Subjects Issues In Research

June 30, 1995

In Congress: Tamoxifen Results Well Communicated, Understood, NCI Says

May 1, 1998